- Home
- SCHL vs IMTX Comparison
SCHL vs IMTX Comparison
Compare SCHL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCHL
- IMTX
- Stock Information
- Founded
- SCHL 1920
- IMTX N/A
- Country
- SCHL United States
- IMTX Germany
- Employees
- SCHL N/A
- IMTX N/A
- Industry
- SCHL Books
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCHL Consumer Discretionary
- IMTX Health Care
- Exchange
- SCHL Nasdaq
- IMTX Nasdaq
- Market Cap
- SCHL 568.7M
- IMTX 653.9M
- IPO Year
- SCHL 1987
- IMTX N/A
- Fundamental
- Price
- SCHL $21.78
- IMTX $5.93
- Analyst Decision
- SCHL
- IMTX Strong Buy
- Analyst Count
- SCHL 0
- IMTX 4
- Target Price
- SCHL N/A
- IMTX $14.67
- AVG Volume (30 Days)
- SCHL 256.5K
- IMTX 734.9K
- Earning Date
- SCHL 07-24-2025
- IMTX 08-12-2025
- Dividend Yield
- SCHL 3.70%
- IMTX N/A
- EPS Growth
- SCHL N/A
- IMTX N/A
- EPS
- SCHL 0.65
- IMTX N/A
- Revenue
- SCHL $1,592,100,000.00
- IMTX $155,801,989.00
- Revenue This Year
- SCHL $3.42
- IMTX N/A
- Revenue Next Year
- SCHL $5.47
- IMTX $1.92
- P/E Ratio
- SCHL $33.15
- IMTX N/A
- Revenue Growth
- SCHL N/A
- IMTX 93.56
- 52 Week Low
- SCHL $15.77
- IMTX $3.30
- 52 Week High
- SCHL $38.77
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- SCHL 65.83
- IMTX 55.46
- Support Level
- SCHL $21.18
- IMTX $5.50
- Resistance Level
- SCHL $22.18
- IMTX $5.82
- Average True Range (ATR)
- SCHL 0.88
- IMTX 0.27
- MACD
- SCHL 0.04
- IMTX -0.03
- Stochastic Oscillator
- SCHL 83.02
- IMTX 50.49
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.